Leaflet INFANRIX-IPV+HIB lyophilisate and suspension for suspension for injection
Indicated for: active immunization
Route of administration: injectable
Substance: DTPA + IPV + HIB combination vaccine (vaccine)
ATC: J07CA06 (Antiinfectives for systemic use | Bacterial and viral vaccines, combined)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The combined DTPa+IPV+Hib vaccine is used for active immunization against diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, and infections caused by Haemophilus influenzae type B (Hib). This vaccine contains acellular components of Bordetella pertussis, diphtheria and tetanus toxoids, inactivated polioviruses, and the Hib capsular polysaccharide conjugated to a carrier protein.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as poliomyelitis, meningitis, and epiglottitis, as well as complications associated with diphtheria, tetanus, and whooping cough.
Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.
The combined DTPa+IPV+Hib vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.
General data about INFANRIX-IPV+HIB
- Substance: DTPA + IPV + HIB combination vaccine
- Date of latest medicines list: 01-01-2014
- Product code: W13418008
- Pharmaceutical form: lyophilisate and suspension for suspension for injection
- Quantity: 100
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.